Area of research
Oncology · Surgery
Research interest
Research interests include Melanoma, Immunology, Antibody, Immune system, Ipilimumab, and Blockade.
Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4
B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma
Enriched circulating and tumor-resident TGF-β <sup>+</sup> regulatory B cells in patients with melanoma promote FOXP3 <sup>+</sup> Tregs
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action
B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin
PAK4 suppresses PDZ-RhoGEF activity to drive invadopodia maturation in melanoma cells
IgG4 subclass antibodies impair antitumor immunity in melanoma